Open AccessPharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia
Author(s) -
S. К. Zyryanov,
I. N. Dyakov
Publication year - 2020
Publication title -
medical technologies assessment and choice
Language(s) - English
Resource type - Journals
eISSN - 2712-7877
pISSN - 2219-0678
DOI - 10.17116/medtech20204002150
Subject(s) - ceftazidime/avibactam , bacteremia , medicine , ceftazidime , pneumonia , carbapenem , intensive care medicine , avibactam , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , biology , bacteria , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom